Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Patient-centered multidisciplinary medication review for frail older adults

Official title: Applying a Multidisciplinary Intervention for Drug Adequacy in a Intermediate Care Hospital (AMIDA-ICH)

Run by Parc Sanitari Pere Virgili · NCT07015112 · Data updated 2026-11-12

This project tests whether a team-led, patient-centered medication review by geriatricians, pharmacists, and nurses can reduce the number of medicines taken by frail older adults admitted to an intermediate care hospital.

More Poly Pharmacy trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment300 (estimated)
SponsorParc Sanitari Pere Virgili
Academic / other
Locations1 site (Barcelona, Barcelona)
StatusRecruiting
StartedJanuary 4, 2024
Main results expectedDecember 2025
Study endsJune 2026
Registry record updatedJune 11, 2025
Trial IDNCT07015112 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Spanish-speaking adults aged 65 or older with three or more chronic conditions who are admitted to the intermediate care hospital and can consent (or have a surrogate to consent).

Probably not a fit

Patients with very short expected hospital stays, limited life expectancy under three months, those who are homeless, or those unable to provide consent are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Older adults admitted to an intermediate care hospital receive a comprehensive geriatric assessment and a structured medication review focused on their goals and clinical characteristics. The multidisciplinary intervention is delivered by geriatricians, clinical pharmacists, and nurses and is compared with the usual medication revision performed by a clinical pharmacist alone. Participants complete questionnaires about their health status and attitudes, and any medication-related adverse events are recorded. The main outcome is change in treatment adequacy, including the average number of medications per patient.

Why it matters

Potential benefit: If successful, this approach could reduce unnecessary medications, lower the risk of adverse drug events, and better align treatments with patients' goals.

How similar studies have gone: Previous multidisciplinary and pharmacist-led deprescribing interventions have often reduced medication counts and inappropriate prescriptions in older adults, although effects on clinical outcomes like hospitalizations and mortality have been mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* older adults (65+ years)
* ≥ 3 or more chronic conditions requiring medical therapy
* able to speak Spanish
* capacity to provide informed consent or have a surrogate able to consent on their behalf

Exclusion Criteria:

* unable to provide informed consent
* anticipated length of hospital stay \< 72h
* estimated life expectancy \< 3 months
* homeless
* already enrolled in a drug trial

Where it's running

  • Parc Sanitari Pere Virgili
    Barcelona, Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.